ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1,2,Iritis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2,1,Abdominal neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
3,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
4,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
4,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
5,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
6,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
7,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
7,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
8,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
8,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
9,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
9,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
9,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
9,4,Blood uric acid increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
9,5,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
9,6,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
9,7,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
10,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
11,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
12,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
12,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
12,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
12,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
12,5,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
12,6,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
12,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
12,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
13,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
13,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
14,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
14,2,Haemorrhage urinary tract,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
15,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
15,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
15,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
16,1,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
16,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
17,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
17,2,Walking disability,Disability issues,Lifestyle issues,SocCi,N
18,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
19,1,Blood calcium abnormal,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
19,2,Cerebral ischaemia,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
19,3,Dissociation,Dissociative states,Dissociative disorders,Psych,N
19,4,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
19,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
19,6,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
19,7,Headache,Headaches NEC,Headaches,Nerv,N
19,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
19,9,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
20,1,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
20,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
20,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
20,4,Splinter haemorrhages,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
21,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
22,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
22,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
22,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
23,1,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
23,2,Tetany,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
24,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
25,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
26,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
26,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
26,3,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
26,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
27,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
27,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
27,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
28,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
29,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
29,2,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
29,3,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
29,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
29,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
29,6,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
29,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
30,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
30,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
30,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
30,4,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
30,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
30,6,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
30,7,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
30,8,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
30,9,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
30,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
30,11,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
30,12,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,Y
30,13,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
30,14,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
30,15,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
30,16,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
30,17,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
31,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
31,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
31,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
31,4,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
31,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
32,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
32,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
33,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
33,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
33,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
33,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
34,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
34,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
34,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
35,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
35,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
36,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
37,1,Hypoparathyroidism,Hypoparathyroid disorders,Parathyroid gland disorders,Endo,N
38,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
38,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
38,3,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
39,1,Blood erythropoietin increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
39,2,Haematocrit increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
39,3,Haemoglobin increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
39,4,Macrocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
39,5,Volume blood decreased,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
40,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
41,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
41,2,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
41,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
42,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
42,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
42,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
42,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
42,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
43,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
43,2,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
44,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
44,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
45,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
46,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
46,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
46,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
46,4,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
47,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
47,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
48,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
48,2,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
48,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
49,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
49,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
49,3,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
50,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
51,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
51,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
51,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
51,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
52,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
52,2,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
53,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
54,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
54,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
54,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
54,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
55,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
55,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
56,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
56,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
57,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
57,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
57,3,Epigastric discomfort,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
57,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
57,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
58,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
58,2,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
58,3,Cardiac flutter,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
58,4,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
58,5,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
58,6,Dental alveolar anomaly,Dental disorders NEC,Dental and gingival conditions,Gastr,N
58,7,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
58,8,Exercise tolerance decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
58,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
58,10,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
58,11,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
58,12,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
58,13,Low cardiac output syndrome,Heart failures NEC,Heart failures,Card,N
58,14,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
58,15,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
58,16,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
58,17,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
58,18,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
58,19,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
59,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
60,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
60,2,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
60,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
60,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
61,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
62,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
62,2,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
62,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
62,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
62,5,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
63,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
64,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
64,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
64,3,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,Y
64,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
64,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
65,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
66,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
67,1,Nephritic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
67,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
67,3,Renal haemorrhage,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
67,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
68,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
68,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
68,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
68,4,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
68,5,Breath sounds abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
68,6,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
68,7,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
68,8,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
68,9,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
68,10,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
68,11,Duodenogastric reflux,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
68,12,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
68,13,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
68,14,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
68,15,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
68,16,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
68,17,Lymphangiosis carcinomatosa,Metastases to specified sites,Metastases,Neopl,N
68,18,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
68,19,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
68,20,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
68,21,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
68,22,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
68,23,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
68,24,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
68,25,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
68,26,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
68,27,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
68,28,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,Y
68,29,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
68,30,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
68,31,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
68,32,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
68,33,Urine odour abnormal,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
68,34,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
69,1,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
69,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
69,3,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
69,4,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
70,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
71,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
71,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
72,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
73,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
74,1,Intertrigo,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
74,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
75,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
76,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
77,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
77,2,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
78,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
79,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
80,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
80,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
81,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
81,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
81,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
82,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
82,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
82,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
82,4,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
83,1,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
83,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
84,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
85,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
86,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
86,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
86,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
86,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
87,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
88,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
88,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
88,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
88,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
89,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
90,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
90,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
90,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
91,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
92,1,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
93,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
93,2,Visual field defect,Visual field disorders,Vision disorders,Eye,N
94,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
95,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
95,2,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
95,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
96,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
97,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
97,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
98,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
98,2,Biliary dilatation,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
98,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
98,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
98,5,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
98,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
98,7,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
98,8,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
98,9,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
99,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
100,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
101,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
101,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
102,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
102,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
102,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
102,4,Dental alveolar anomaly,Dental disorders NEC,Dental and gingival conditions,Gastr,N
102,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
102,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
102,7,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
102,8,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
102,9,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
102,10,Low cardiac output syndrome,Heart failures NEC,Heart failures,Card,N
102,11,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
102,12,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
102,13,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
103,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
103,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
103,3,Headache,Headaches NEC,Headaches,Nerv,N
103,4,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
104,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
104,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
104,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
104,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
104,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
104,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
105,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
106,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
106,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
107,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
108,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
109,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
109,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
109,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
110,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
110,2,Tumour haemorrhage,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
111,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
111,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
111,3,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
112,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
112,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
112,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
112,4,Mediastinal haemorrhage,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
112,5,Tumour necrosis,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
113,1,Hepatorenal failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
114,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
114,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
115,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
116,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
117,1,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
118,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
118,2,Cardiac valve disease,Cardiac valve disorders NEC,Cardiac valve disorders,Card,N
119,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
119,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
119,3,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
119,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
119,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
119,6,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
119,7,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
119,8,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
119,9,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
119,10,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
120,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
121,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
121,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
121,3,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
121,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
121,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
121,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
122,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
123,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
123,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
123,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
124,1,Intra-abdominal haematoma,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
124,2,Intra-abdominal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
125,1,Intra-abdominal haematoma,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
125,2,Intra-abdominal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
126,1,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
127,1,Diverticular perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
127,2,Ileus paralytic,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
128,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
128,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
129,1,Cor pulmonale,Right ventricular failures,Heart failures,Card,Y
129,2,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
130,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
131,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
131,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
131,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
131,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
131,5,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
132,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
132,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
132,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
132,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
132,5,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
132,6,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
132,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
132,8,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
132,9,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
132,10,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
132,11,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
132,12,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
132,13,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
132,14,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
132,15,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
132,16,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
132,17,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
132,18,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
132,19,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
132,20,Testicular haemorrhage,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
132,21,Testicular swelling,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
132,22,Urine flow decreased,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
132,23,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
133,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
134,1,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
135,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
135,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
135,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
135,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
135,5,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
135,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
136,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
136,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
137,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
137,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
138,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
138,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
138,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
139,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
140,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
141,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
141,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
141,3,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
141,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
141,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
142,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
142,2,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
143,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
144,1,Torsade de pointes,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
145,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
145,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
145,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
145,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
145,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
145,6,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
146,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
146,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
146,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
146,4,Headache,Headaches NEC,Headaches,Nerv,N
146,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
146,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
146,7,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
146,8,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
146,9,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
146,10,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
147,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,Y
148,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
149,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
149,2,Blood bilirubin abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
149,3,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
149,4,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
149,5,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
149,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
150,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
150,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
150,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
150,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
150,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
150,6,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
150,7,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
150,8,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
150,9,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
150,10,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
151,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
151,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
152,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
153,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
153,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
154,1,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
154,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
154,3,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
155,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
156,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
156,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
157,1,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
158,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
158,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
159,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
159,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
159,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
160,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
161,1,Macrocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
162,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
163,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
164,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
165,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
165,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
165,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
166,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
167,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
167,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
167,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
167,4,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
167,5,Headache,Headaches NEC,Headaches,Nerv,N
167,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
167,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
168,1,Bruxism,Stereotypies and automatisms,Changes in physical activity,Psych,N
168,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
168,3,Trismus,Muscle tone abnormalities,Muscle disorders,Musc,N
169,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
170,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
170,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
170,3,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
170,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
170,5,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
170,6,Spinal operation,Spine and spinal cord therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
171,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
171,2,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
171,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
171,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
171,5,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
171,6,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
172,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
172,2,Gastrointestinal stromal tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
172,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
172,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
173,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
173,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
173,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
173,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
173,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
174,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
174,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
175,1,Gastritis erosive,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
175,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
175,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
176,1,Blood creatinine decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
176,2,Blood urea decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
176,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
176,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
176,5,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
176,6,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
176,7,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
176,8,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
176,9,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
176,10,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
176,11,Underweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
176,12,Urine phosphorus increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
177,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
178,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
178,2,Gastrointestinal stromal tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
178,3,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
178,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
178,5,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
178,6,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
179,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
180,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
181,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
181,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
181,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
181,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
182,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
182,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
182,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
183,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
184,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
184,2,Conjunctival disorder,"Conjunctival structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
184,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
185,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
185,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
185,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
186,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
187,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
188,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
189,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
190,1,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
190,2,Bone lesion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
190,3,Bone swelling,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
190,4,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
190,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
190,6,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
190,7,Lymph node pain,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
190,8,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
190,9,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
190,10,Oncologic complication,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
190,11,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
190,12,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
190,13,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
191,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
191,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
191,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
191,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
192,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
193,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
194,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
194,2,Gastrointestinal stromal tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
194,3,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
194,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
195,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
195,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
195,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
195,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
195,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
196,1,Superficial vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
197,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
197,2,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
197,3,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
197,4,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
197,5,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
197,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
197,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
197,8,Gastrointestinal stromal tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
197,9,Hepatic mass,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
197,10,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
197,11,Lip dry,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
197,12,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
197,13,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
197,14,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
197,15,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
197,16,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
197,17,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
198,1,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
198,2,Bone sequestrum,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
198,3,Gingival recession,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
198,4,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
198,5,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
198,6,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
198,7,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
199,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
199,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
199,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
199,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
200,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
201,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
201,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
201,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
202,1,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
202,2,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
203,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
204,1,Headache,Headaches NEC,Headaches,Nerv,N
204,2,Pituitary haemorrhage,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
204,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
205,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,Y
206,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
206,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
206,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
206,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
206,5,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
206,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
206,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
207,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
207,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
207,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
207,4,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
208,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
208,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
209,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
210,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
210,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
211,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
211,2,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
212,1,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
213,1,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
214,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
215,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
215,2,Coronary artery occlusion,Coronary artery disorders NEC,Coronary artery disorders,Card,N
216,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
216,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
216,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
216,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
216,5,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
216,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
217,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
217,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
217,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
217,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
217,5,Torsade de pointes,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
217,6,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
217,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
218,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
219,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
219,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
219,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
219,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
219,5,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
219,6,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
220,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
220,2,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
220,3,Renal cancer,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
221,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
221,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
221,3,Gastrointestinal stromal tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
221,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
221,5,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
221,6,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
222,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
223,1,Drug tolerance decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
223,2,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
223,3,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
224,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
224,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
224,3,Headache,Headaches NEC,Headaches,Nerv,N
224,4,Malignant hypertension,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
224,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
224,6,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
224,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
224,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
225,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
225,2,Exposed bone in jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
225,3,Gingival recession,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
225,4,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
226,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
226,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
226,3,Gastrointestinal stromal tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
226,4,Gene mutation identification test positive,Gene analyses,Cytogenetic investigations and genetic analyses,Inv,N
226,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
226,6,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
226,7,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
227,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
227,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
228,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
228,2,Exposed bone in jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
228,3,Fistula,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
228,4,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
228,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
228,6,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
228,7,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
228,8,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
228,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
228,10,Soft tissue infection,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
228,11,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
229,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
230,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
231,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
232,1,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
233,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
233,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
233,3,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
234,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
235,1,Intracranial aneurysm,Central nervous system aneurysms and dissections,Central nervous system vascular disorders,Nerv,N
235,2,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
236,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
236,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
236,3,Gastrointestinal stromal tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
236,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
236,5,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
236,6,Metastases to peritoneum,Metastases to specified sites,Metastases,Neopl,N
237,1,Blood creatinine abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
237,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
237,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
237,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
238,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
238,2,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
238,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
239,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
240,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
241,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
242,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
242,2,Gastrointestinal stromal tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
242,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
242,4,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
242,5,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
243,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
243,2,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
243,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
244,1,Gastrointestinal inflammation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
244,2,Gastrointestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
245,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
245,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
245,3,Gastrointestinal stromal tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
245,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
245,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
245,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
245,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
246,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
247,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
247,2,Acute abdomen,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
247,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
247,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
247,5,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
247,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
247,7,Mesenteric arteriosclerosis,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
247,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
247,9,Orbital oedema,"Orbital structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
247,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
248,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
248,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
248,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
248,4,Gastrointestinal ulcer,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
248,5,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
248,6,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,Y
248,7,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
248,8,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
248,9,Performance status decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
248,10,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
248,11,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
249,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
250,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
251,1,Exposed bone in jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
251,2,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
251,3,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
252,1,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
252,2,Osteitis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
252,3,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
253,1,Gingival disorder,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
253,2,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
253,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
254,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
254,2,Oesophageal haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
254,3,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
255,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
255,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
255,3,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
255,4,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
255,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
256,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
256,2,Performance status decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
257,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
258,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
259,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
260,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
260,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
260,3,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
260,4,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
260,5,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
261,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
261,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
261,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
261,4,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
261,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
262,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
263,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
264,1,Anorectal disorder,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
264,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
264,3,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
265,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
265,2,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
266,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
266,2,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
266,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
267,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
267,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
267,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
267,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
267,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
268,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
269,1,Renal haemorrhage,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
270,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
270,2,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
271,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
271,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
272,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
273,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
273,2,Anisocoria,Pupil disorders,Ocular neuromuscular disorders,Eye,N
273,3,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
273,4,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
273,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
273,6,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
273,7,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
273,8,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
273,9,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
273,10,Myocardial necrosis marker increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
273,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
273,12,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
273,13,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
273,14,Resuscitation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
273,15,Torsade de pointes,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
273,16,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
273,17,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
274,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
274,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
274,3,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
274,4,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
275,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
276,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
276,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
277,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
278,1,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
279,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
279,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
280,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
280,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
280,3,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
281,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
281,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
282,1,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,Y
282,2,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
283,1,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,Y
284,1,Aortic dissection,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
285,1,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
286,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
286,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
286,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
286,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
286,5,Gastritis erosive,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
286,6,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
286,7,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
286,8,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
286,9,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
286,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
287,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
287,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
287,3,Splinter haemorrhages,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
288,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
288,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
288,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
288,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
288,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
289,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
289,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
290,1,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
290,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
291,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
291,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
291,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
291,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
292,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
292,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
292,3,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
292,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
293,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
294,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
294,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
294,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
294,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
294,5,Spider vein,Varicose veins NEC,Venous varices,Vasc,N
295,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
295,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
295,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
296,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
297,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
297,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
297,3,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
298,1,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
299,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
299,2,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
299,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
300,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
300,2,Hypoglycaemic coma,Coma states,Neurological disorders NEC,Nerv,N
301,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
301,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
301,3,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
301,4,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
301,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
302,1,Genital rash,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
302,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
303,1,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
304,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
304,2,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,Y
305,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
306,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
307,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
308,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
309,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
310,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
310,2,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,Y
311,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
312,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
312,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
312,3,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
313,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
314,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
314,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
315,1,Acute pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
316,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
316,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
317,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
317,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
318,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
318,2,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
318,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
318,4,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
318,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
318,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
319,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
319,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
319,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
319,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
319,5,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
320,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
320,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
320,3,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
320,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
321,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
321,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
321,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
321,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
322,1,Chronic lymphocytic leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
322,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
322,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
322,4,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
322,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
323,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
324,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
325,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
326,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
326,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
327,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
328,1,Enterocolitis haemorrhagic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
329,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
330,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
331,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
331,2,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
332,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
332,2,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
332,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
332,4,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
332,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
332,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
332,7,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
332,8,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
332,9,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
332,10,Tumour haemorrhage,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
333,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
333,2,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
333,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
333,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
333,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
333,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
333,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
333,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
334,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
335,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
335,2,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
336,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
337,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
338,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
339,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
340,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
341,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
342,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
343,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
344,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
345,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
345,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
345,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
346,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
347,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
347,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
347,3,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
347,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
348,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
348,2,Oesophageal stenosis,Oesophageal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
348,3,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
348,4,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
349,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
349,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
349,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
349,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
350,1,Acquired haemophilia,Coagulation factor deficiencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
351,1,Acquired haemophilia,Coagulation factor deficiencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
352,1,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
353,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
353,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
353,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
353,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
353,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
353,6,Exercise tolerance decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
353,7,Hepatic enzyme abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
353,8,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
353,9,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
353,10,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
353,11,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
354,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
354,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
354,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
354,4,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
354,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
355,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
355,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
355,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
355,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
356,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
356,2,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
356,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
357,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
357,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
357,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
357,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
357,5,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
357,6,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
357,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
357,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
358,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
359,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
359,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
359,3,Blood sodium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
359,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
359,5,Deafness,Hearing losses,Hearing disorders,Ear,N
359,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
359,7,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
359,8,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
359,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
359,10,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
359,11,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
359,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
359,13,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
359,14,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
359,15,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
359,16,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
359,17,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
359,18,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
360,1,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
361,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
362,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
362,2,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
362,3,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
362,4,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
362,5,Trichorrhexis,Pilar disorders NEC,Skin appendage conditions,Skin,N
362,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
363,1,Gastrointestinal stromal tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
363,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
364,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
364,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
364,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
364,4,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
364,5,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
365,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
365,2,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
366,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
366,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
366,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
367,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
368,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
368,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
368,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
369,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
369,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
369,3,Headache,Headaches NEC,Headaches,Nerv,N
369,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
369,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
369,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
369,7,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
369,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
370,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
370,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
370,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
370,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
371,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
372,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
372,2,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
372,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
372,4,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
372,5,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
373,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
373,2,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
373,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
373,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
373,5,Renal cancer metastatic,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
374,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
375,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
375,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
375,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
375,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
375,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
375,6,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
375,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
375,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
375,9,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
375,10,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
375,11,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
375,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
376,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
377,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
377,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
377,3,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
377,4,Death,Death and sudden death,Fatal outcomes,Genrl,Y
377,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
377,6,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
377,7,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
377,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
377,9,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
377,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
377,11,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
377,12,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
377,13,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
377,14,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
377,15,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
377,16,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
377,17,Sacral pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
377,18,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
377,19,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
377,20,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
378,1,Scrotal infection,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
379,1,Deafness,Hearing losses,Hearing disorders,Ear,N
379,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
379,3,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
379,4,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
380,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
381,1,Migraine,Migraine headaches,Headaches,Nerv,N
382,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
383,1,Giant cell arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
383,2,Headache,Headaches NEC,Headaches,Nerv,N
383,3,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
384,1,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
385,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
385,2,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
386,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
386,2,Exposure via partner,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
387,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
387,2,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,Y
388,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
388,2,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
389,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
390,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
390,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
390,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
390,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
390,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
391,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
392,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
392,2,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
393,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
393,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
393,3,Haemoperitoneum,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
393,4,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
393,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
393,6,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
393,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
393,8,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
393,9,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
393,10,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
393,11,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
393,12,Renal vein thrombosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
393,13,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
394,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
394,2,Gastrointestinal stromal tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
394,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
394,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
395,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
395,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
396,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
396,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
397,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
398,1,Gastrointestinal stromal tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
398,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
398,3,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
398,4,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
399,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
399,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
400,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
400,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
401,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,Y
401,2,Hepatorenal syndrome,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
402,1,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
402,2,Glomerular filtration rate increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
402,3,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
402,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
402,5,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
403,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
403,2,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
403,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
403,4,Hepatorenal failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
404,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
404,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
405,1,Gastrointestinal stromal tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
405,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
406,1,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
406,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
406,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
406,4,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
407,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
407,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
407,3,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
407,4,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
408,1,Bone lesion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
408,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
408,3,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
408,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
409,1,Acute promyelocytic leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
409,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
409,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
409,4,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
409,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
410,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
411,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
411,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
411,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
411,4,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
411,5,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
411,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
411,7,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
412,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
412,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
413,1,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
413,2,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
413,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
413,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
414,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
414,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
414,3,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
415,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
416,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
416,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
416,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
416,4,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
416,5,Urine protein/creatinine ratio increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
417,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
417,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
417,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
418,1,Metastases to pancreas,Metastases to specified sites,Metastases,Neopl,Y
419,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
419,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
419,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
419,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
419,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
419,6,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
419,7,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
419,8,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
420,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
420,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
420,3,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
420,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
421,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
422,1,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
422,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
422,3,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
422,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
422,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
423,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
423,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
423,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
423,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
423,5,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
423,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
423,7,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
423,8,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
423,9,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
423,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
423,11,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
423,12,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
423,13,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
423,14,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
424,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
424,2,Gastric perforation,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
424,3,Pneumoperitoneum,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
425,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
425,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
426,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
426,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
426,3,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
426,4,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
426,5,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
427,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
427,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
427,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
428,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
428,2,Metastases to pleura,Metastases to specified sites,Metastases,Neopl,N
429,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
430,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
430,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
430,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
430,4,Hyperacusis,Hyperacusia,Hearing disorders,Ear,N
430,5,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
430,6,Migraine,Migraine headaches,Headaches,Nerv,N
430,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
430,8,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
430,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
430,10,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
430,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
430,12,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
431,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
431,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
431,3,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
431,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
431,5,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
431,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
431,7,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
431,8,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
431,9,Renal cell carcinoma stage IV,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,Y
431,10,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
431,11,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
431,12,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
432,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
433,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
434,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
434,2,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
434,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
434,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
434,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
434,6,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
434,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
434,8,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
434,9,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
434,10,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
434,11,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
434,12,Sluggishness,Asthenic conditions,General system disorders NEC,Genrl,N
435,1,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
435,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
435,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
435,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
435,5,Intervertebral disc protrusion,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
435,6,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
435,7,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
435,8,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
435,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
435,10,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
435,11,Otorrhoea,Ear disorders NEC,Aural disorders NEC,Ear,N
435,12,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
435,13,Tympanic membrane disorder,Tympanic membrane disorders (excl infections),Middle ear disorders (excl congenital),Ear,N
436,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
436,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
436,3,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
436,4,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
436,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
436,6,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
436,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
436,8,Skin candida,Candida infections,Fungal infectious disorders,Infec,N
436,9,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
436,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
436,11,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
437,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
438,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
439,1,Gastrointestinal stromal tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
439,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
440,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
441,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
441,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
442,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
442,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
442,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
442,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
442,5,Freezing phenomenon,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
442,6,Hepatic cancer metastatic,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
442,7,Lung cancer metastatic,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
442,8,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
442,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
442,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
442,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
443,1,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
443,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
443,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
443,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
444,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
444,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
444,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
445,1,Cystoid macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
445,2,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
445,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
446,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
446,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
446,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
446,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
446,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
446,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
446,7,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
447,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
448,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
448,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
448,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
448,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
448,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
448,6,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
448,7,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
448,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
448,9,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
448,10,Renal cancer metastatic,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
448,11,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
448,12,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
448,13,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
449,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
449,2,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
449,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
450,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
451,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
452,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
452,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
452,3,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
452,4,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
453,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
453,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
454,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
454,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
454,3,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
455,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
455,2,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,Y
456,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
456,2,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
456,3,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
457,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
457,2,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
458,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
458,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
458,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
458,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
459,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
459,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
459,3,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
460,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
460,2,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,Y
461,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
461,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
461,3,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
461,4,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
462,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
462,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
462,3,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
463,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
463,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
463,3,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
464,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
464,2,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,Y
465,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
465,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
465,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
466,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
467,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
467,2,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
467,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
468,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
469,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
469,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
469,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
470,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
470,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
471,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
471,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
471,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
471,4,Ileus paralytic,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
471,5,Pancreatic neuroendocrine tumour,Islet cell neoplasms and APUDoma NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
471,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
472,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
472,2,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
472,3,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
472,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
472,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
472,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
473,1,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
473,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
473,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
474,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
475,1,Eyelash discolouration,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
475,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
475,3,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
476,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
477,1,Biliary sepsis,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
478,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
479,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
480,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
481,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
482,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
482,2,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
482,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
482,4,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
482,5,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
482,6,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
483,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
484,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
485,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
485,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
486,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
487,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
487,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
487,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
487,4,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
487,5,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
487,6,Perineal abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
487,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
488,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
488,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
489,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
489,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
490,1,Malaria,Plasmodia infections,Protozoal infectious disorders,Infec,N
491,1,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
491,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
492,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
492,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
492,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
492,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
492,5,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
492,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
492,7,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
492,8,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
492,9,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
493,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
493,2,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
493,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
493,4,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
493,5,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
493,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
493,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
493,8,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
494,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
494,2,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
494,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
494,4,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
494,5,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
494,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
495,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
495,2,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
495,3,Headache,Headaches NEC,Headaches,Nerv,N
495,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
495,5,Septic encephalopathy,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
496,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
496,2,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
496,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
497,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
497,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
497,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
498,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
499,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
499,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
499,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
499,4,Oral infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
499,5,Rectal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
500,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
501,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
501,2,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
502,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
502,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
503,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
503,2,Coronary artery dissection,Coronary artery disorders NEC,Coronary artery disorders,Card,N
504,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
504,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
504,3,Coronary artery dissection,Coronary artery disorders NEC,Coronary artery disorders,Card,N
504,4,Troponin I increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
505,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
505,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
505,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
505,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
505,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
506,1,Animal scratch,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
506,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
506,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
506,4,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
506,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
506,6,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
506,7,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
506,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
506,9,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
506,10,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
506,11,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
507,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
507,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
507,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
507,4,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
507,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
507,6,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
507,7,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
507,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
508,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
508,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
508,3,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
508,4,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
508,5,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
508,6,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
508,7,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
508,8,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
508,9,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
508,10,Blood urine,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
508,11,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
508,12,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
508,13,Demodicidosis,Ectoparasitic infestations,Ectoparasitic disorders,Infec,N
508,14,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
508,15,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
508,16,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
508,17,Glycosylated haemoglobin decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
508,18,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
508,19,Hyperchlorhydria,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
508,20,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
508,21,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
508,22,Ingrowing nail,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
508,23,Inguinal hernia,Inguinal hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
508,24,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
508,25,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
508,26,Muscle mass,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
508,27,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
508,28,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
508,29,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
508,30,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
508,31,Post herpetic neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
508,32,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
508,33,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
508,34,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
508,35,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
508,36,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
508,37,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
509,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
509,2,Listless,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
510,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
510,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
510,3,Blood thyroid stimulating hormone decreased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
510,4,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
510,5,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
510,6,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
510,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
510,8,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
510,9,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
510,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
510,11,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
510,12,Hypoventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
510,13,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
510,14,Muscle strain,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
510,15,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
510,16,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
510,17,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
510,18,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
510,19,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
510,20,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
510,21,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
511,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
511,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
511,3,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
511,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
511,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
511,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
512,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
512,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
513,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
513,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
514,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
514,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
514,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
515,1,Antipsychotic drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
515,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
515,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
515,4,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
515,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
515,6,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
515,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
515,8,Renal cancer metastatic,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
515,9,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
515,10,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
516,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
516,2,Headache,Headaches NEC,Headaches,Nerv,N
516,3,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
516,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
516,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
517,1,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
517,2,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
517,3,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
518,1,Bone marrow disorder,Haematological disorders,Haematological disorders NEC,Blood,N
518,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
518,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
518,4,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
518,5,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
518,6,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
518,7,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
519,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
519,2,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
520,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
520,2,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
520,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
521,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
521,2,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
522,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
522,2,Renal cancer metastatic,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
522,3,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
523,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
523,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
523,3,Performance status decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
524,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
524,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
524,3,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
524,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
525,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
525,2,Blood chromogranin A increased,"Gastrointestinal, pancreatic and APUD hormone analyses",Endocrine investigations (incl sex hormones),Inv,N
525,3,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
525,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
525,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
525,6,Parathyroid hormone-related protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
525,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
526,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
526,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
527,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
528,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
528,2,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
529,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
530,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
530,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
531,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
532,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
532,2,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
532,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
532,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
532,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
532,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
532,7,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
532,8,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
532,9,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
533,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
533,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
533,3,Stoma site haemorrhage,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
534,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
534,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
535,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
535,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
536,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
536,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
536,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
537,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
538,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
538,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
538,3,Cardiac failure,Heart failures NEC,Heart failures,Card,N
538,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
538,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
538,6,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
538,7,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
538,8,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
538,9,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
538,10,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
538,11,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
538,12,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
538,13,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
538,14,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
539,1,Arteriospasm coronary,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
539,2,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
539,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
539,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
539,5,Electrocardiogram ST-T segment abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
539,6,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
539,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
539,8,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
539,9,Ventricular hypokinesia,Myocardial disorders NEC,Myocardial disorders,Card,N
540,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
540,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
541,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
542,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
542,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
542,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
543,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
543,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
544,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
544,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
544,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
544,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
545,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
545,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
546,1,Groin abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
546,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
546,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
546,4,Pyelonephritis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
546,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
547,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
548,1,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,Y
549,1,Cerebral microhaemorrhage,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
549,2,Communication disorder,Communications disorders,Communication disorders and disturbances,Psych,N
549,3,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
549,4,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
550,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
550,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
550,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
551,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
551,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
552,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
553,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
554,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
555,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
555,2,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
555,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
555,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
555,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
555,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
555,7,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
555,8,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
555,9,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
555,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
555,11,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
555,12,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
555,13,Periodontal disease,Dental disorders NEC,Dental and gingival conditions,Gastr,N
555,14,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
556,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
557,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
557,2,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
557,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
558,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
559,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
560,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
561,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
562,1,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
563,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
564,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
565,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
566,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
567,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
567,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
567,3,Pancreatic neuroendocrine tumour,Islet cell neoplasms and APUDoma NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
567,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
568,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
568,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
568,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
569,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
569,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
569,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
569,4,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
569,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
569,6,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
569,7,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
569,8,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
569,9,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
569,10,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
569,11,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
569,12,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
569,13,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
569,14,Pancreatic neuroendocrine tumour,Islet cell neoplasms and APUDoma NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
569,15,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
569,16,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
569,17,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
569,18,Tumour necrosis,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
570,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
571,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
571,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
571,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
572,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
572,2,Gastrointestinal stromal tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
572,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
573,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
573,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
574,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
574,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
574,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
575,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
576,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
576,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
577,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
578,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
